Progesterone receptor modulates ERα action in breast cancer.
about
Mechanisms of oestrogen receptor (ER) gene regulation in breast cancerNeoadjuvant endocrine therapy in breast cancer: current role and future perspectivesTargeting Breast Cancer MetastasisAccurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersAndrogen Receptor: A Complex Therapeutic Target for Breast CancerPeroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone2016 update of the PRIDE database and its related toolsDeciphering the divergent roles of progestogens in breast cancer.Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programsMinireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling indexHDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk.Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.Systematic identification of Ctr9 regulome in ERα-positive breast cancerSex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.Endocrine resistance in breast cancer--An overview and update.Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysisIdentifications of novel mechanisms in breast cancer cells involving duct-like multicellular spheroid formation after exposure to the Random Positioning MachineGenomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and MetastasisDistinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterusWNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI.Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer CellsNeoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation.Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids.Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.Accurate Control of 17β-Estradiol Long-Term Release Increases Reliability and Reproducibility of Preclinical Animal Studies.Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity.The effect of androgen receptor expression on clinical characterization of metastatic breast cancerIntegrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomizationThe contribution of mass spectrometry-based proteomics to understanding epigenetics.
P2860
Q26765380-C6EA8982-E66D-402B-9E7A-984B970E6038Q26773012-5BC05B96-79D4-4C7C-BEE5-983E145E267FQ26783925-6D2C9620-0385-4A4C-9EE7-011FF0B149EAQ28069856-13F5F70A-2291-4DEC-84AA-80EE0FF7796FQ28075188-621C11C7-B573-43A2-9776-B9542A5951B9Q28553997-0913B2FB-532F-448B-B009-D3094F0FAF66Q28603110-C9553DEF-821B-43BB-8CE2-4C996287CCC4Q30240711-315CE2CA-3B06-43D1-BABC-EF989B004141Q33568421-A5121A01-DFAF-4A91-BE76-C010C9B231DDQ33631557-963537B9-A1E9-4BA5-BA51-7926ACABAE29Q33717341-150C4E54-BCEA-4D8F-8087-73CCA0A8C710Q33733042-EC19A0AB-23B1-4222-917E-7F6AF2D108E0Q34549156-D5EA6CEC-6EB2-4BA8-B926-B47EA734BE9FQ36027031-12E31123-DD0A-485F-B17E-C3F1009C0F5BQ36085343-724BC1C7-DC0D-4885-AFCC-95EC48E2C8B7Q36187708-D84C0283-4C59-4491-8E73-0AEDDDD96104Q36243394-509B389C-96EE-4C8D-87CF-F1998671CED0Q36386322-E46B533C-B9AF-45BD-8928-BA062EE258DBQ36680439-CA57C35F-01B9-4188-A3B9-1C10F29D4DC9Q36799235-CA2CDA0C-22CD-4ACE-B929-F4ADE5E91C2CQ36905846-C5F21B56-1328-4069-B18A-C000B567F28EQ36941381-3023989D-A5E1-4CCF-BEDE-32515B3B0418Q37056109-CE9A327A-C615-4C89-9AAB-05E981FBB33DQ37100069-A7BF3AE2-7E90-4B22-A80C-FC7504A63AB7Q37109504-7E442B85-0132-4A4F-ACB4-DF80FB6703EAQ37267630-52E3E785-D9BC-442D-959F-2D3EEDF5C17AQ37319203-46984177-A3D7-44B0-9B1F-48C8F5967B09Q37372273-9C0E4ECB-3EAB-4FFF-906F-CB5D28362E06Q37376167-979C3374-345F-41EE-8F85-7F39F9C72E6DQ37393180-40E9B3FC-D659-4594-8934-EEFF342DB147Q37564411-8AE0EA8A-0F73-4D8A-A72E-35BD8886D3A4Q37594444-C062225E-413B-499F-ACD5-05975F74E7F6Q37643402-C228117C-1E6C-4817-91BE-22CD298146E6Q37696099-A3940104-10B8-4A47-9AFA-E1C7178BB9DDQ37702781-9F9282B4-47CA-4318-8607-62438C5BE2E6Q37706554-A826FD4B-BC32-4F1E-9B6D-92A0A33ADCE9Q37729055-3E1EBA7A-0BF2-42FE-A6DB-F347D9E2E6F1Q38590446-3F44DD03-9C72-49F6-AAF5-3EE9218C638EQ38599114-F20D84E0-0CD7-41BF-B4F1-CF1ABE58D90AQ38647501-DB8B7715-D1C8-4A65-9D7C-01A0D96629B7
P2860
Progesterone receptor modulates ERα action in breast cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Progesterone receptor modulates ERα action in breast cancer
@nl
Progesterone receptor modulates ERα action in breast cancer.
@ast
Progesterone receptor modulates ERα action in breast cancer.
@en
type
label
Progesterone receptor modulates ERα action in breast cancer
@nl
Progesterone receptor modulates ERα action in breast cancer.
@ast
Progesterone receptor modulates ERα action in breast cancer.
@en
prefLabel
Progesterone receptor modulates ERα action in breast cancer
@nl
Progesterone receptor modulates ERα action in breast cancer.
@ast
Progesterone receptor modulates ERα action in breast cancer.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Progesterone receptor modulates ERα action in breast cancer.
@en
P2093
Alejandra Bruna
Amel Saadi
Aurelien A Serandour
Clive D'Santos
Ganesh V Raj
Gordon D Brown
Grace Silva
I Alasdair Russell
James Hadfield
Jason S Carroll
P2860
P2888
P304
P3181
P356
10.1038/NATURE14583
P407
P50
P577
2015-07-08T00:00:00Z
P5875
P6179
1049985559